Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?

The aim of the present study was to evaluate whether prostate cancer (PC) patients can be accurately classified on the bases of tissue expression of gastrin-releasing peptide receptor (GRPR) and prostate-specific membrane antigen (PSMA). This retrospective study included 28 patients with PC. Formali...

Descripción completa

Detalles Bibliográficos
Autores principales: Faviana, Pinuccia, Boldrini, Laura, Erba, Paola Anna, Di Stefano, Iosè, Manassero, Francesca, Bartoletti, Riccardo, Galli, Luca, Gentile, Carlo, Bardi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039448/
https://www.ncbi.nlm.nih.gov/pubmed/33854977
http://dx.doi.org/10.3389/fonc.2021.650249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039448/
https://www.ncbi.nlm.nih.gov/pubmed/33854977
http://dx.doi.org/10.3389/fonc.2021.650249

Ejemplares similares